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Abstract
Background: We aimed to investigate the molecular epidemiology of Mycobacterium tuberculosis complex (MTBC)
isolates in the province of Palermo, Sicily, Italy, by characterizing 183 isolates identified in the years 2004–2012. A
comparison with 104 MTBC strains identified in the same geographic area in the years 1994–2000 was also carried out.
Methods: One hundred eighty-three MTBC isolates identified in Palermo, Italy, in the years 2004–2012 were analyzed
by spoligotyping and the 24 mycobacterial interspersed repetitive unit (MIRU)-variable-number tandem-repeat (VNTR)
method typing. Susceptibility testing to streptomycin, isoniazid, rifampin and ethambutol was also performed.
Furthermore, the spoligotyping dataset obtained from 104 MTBC isolates identified from 1994 to 2000 was reanalyzed.
Distribution into lineages and clustering of isolates in the two periods was compared.
Results: One hundred seventy-seven out of the 183 isolates of MTBC submitted to molecular typing were fully
characterized. Of these, 108 were from Italian-born and 69 from foreign-born individuals. Eleven different lineages and
35 families-subfamilies were identified with the most represented lineages being Haarlem (26.5%), T (19.2%), LAM
(13.6%) and S (8.5%). Except for the Haarlem lineage, where isolates from foreign-born patients were overrepresented,
the distribution of isolates in the families belonging to the Euro-American clone reflected the proportions of the two
subpopulations. A total of 27 (15.2%) strains were clustered and three clusters were mixed. Approximately 25% of the
183 MTBC isolates under study proved to be resistant to at least one antiTB drug, with only three isolates categorized
as multidrug resistant (MDR). When MTBC isolates identified in the years 1994–2000 were reanalyzed, lineages T (30.8%),
LAM (29.8%), Haarlem (16.3%) and S (13.5%) proved to be predominant. No MTBC isolates belonging to CAM, U, CAS,
Turkish and Ural lineages were identified.
Conclusions: A wide heterogeneity was detected among the MTBC strains isolated in the years 2004–2012. Six
lineages were not present among the isolates of the period 1994–2000. Comparison between distribution of lineages
in the two consecutive periods depicts rapid and deep changes in the TB epidemiology in Palermo, Italy. An universal
and continued laboratory-based surveillance of TB in Sicily is required.
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Background
Tuberculosis (TB) is still a prominent cause of morbidity
and mortality all over the world. The epidemiology of
TB in low endemic western countries is strongly influ-
enced by immigration from high endemic countries
[1,2]. According with the more recent European Centre
for Disease Prevention and Control (ECDC) surveillance
report focusing the TB epidemiological situation, in
2012 the overall proportion of TB cases of foreign origin
in the European Union/European Economic Area (EU/
EEA) was 26.8% with some northern European countries
showing rates as high as 85.4% [3]. An accurate assess-
ment of the impact of this phenomenon is indispensable
for planning adequate control and prevention strategies.
However, this objective is increasingly proving to be
more challenging than expected. Indeed, in low EU/EEA
prevalence countries, TB is now predominant in hard-
to-reach, vulnerable population groups, mainly including
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socially excluded individuals, such as prisoners, drug ad-
dicts, homeless persons, recent and illegal immigrants [3].
These subjects are at high risk to be diagnosed and treated
late and to trigger unrecognized transmission chains [1,3].
The sharp increase in immigration from high endemic
countries is especially perceived as a cause of concern.
Nevertheless, several studies conducted in some low-
endemic European countries, including Italy, and a recent
systematic review provide consistent evidence that TB in a
foreign-born population does not significantly influence
TB in the native population, although it contributes to in-
crease the total number of cases of disease [2,4-8].
In recent years immigration to Sicily, Italy, is increas-
ing, often under the form of acute waves from the north-
ern African shores. However, Sicily represents for most
immigrants an intermediate step in their travel towards
more economically appealing European countries. Con-
sequently, the number of immigrants living in Sicily has
raised from 24 900 in 1991 to about 140 000 in 2013,
but their prevalence on the overall regional population is
just 2.8% [9]. In 2013 Palermo and its province has reg-
istered about 29 000 resident immigrants, roughly doub-
ling the proportion reported at the beginning of 2000s.
Some demographic features are of special interest, such
as a) the increase in the Romanian component, mainly
following the accession to the EU since 2007, this com-
munity having become the main one in the island (about
20% of overall immigrants); b) the persistence of older
established communities such as, for instance, Tunisians,
Moroccans, Sri Lanka and Albanians; c) the increasing
heterogeneity of the countries of origin, now accounting
for more than 50, from the African continent to Latin
America, from Asia to East Europe [10]. In the decade
1999–2008, according with the data provided by the
Italian Health Ministry, the TB incidence in Sicily aver-
aged 2.6 (0.9-3.5) per 100 000 population [11]. In 2008,
in particular, the raw incidence of TB among foreign-
born inhabitants was 11.2 per 100 000 compared to 0.7
per 100 000 in the autochthonous population. However,
underreporting is very likely when considering that in
the years 2003–2008 in Italy the incidence per 100 000
population declined from 5.1 to 3.8 in the Italian born
inhabitants and ranged between 49.3 and 51.9 in the for-
eign born inhabitants [11].
Molecular epidemiology is increasingly used as a com-
plementary tool to conventional epidemiology. Large “spoli-
gotype” databases, describing the worldwide diversity of
Mycobacterium tuberculosis complex (MTBC) clustered
regularly interspaced short palindromic repeats (CRISPR)
loci, have been released, allowing local epidemiological find-
ings of MTBC to be studied in comparison with the global
landscape [12]. Combining spoligotyping and 24 mycobac-
terial interspersed repetitive unit (MIRU)-variable-number
tandem-repeat (VNTR) loci analysis has now replaced the
traditional IS6110-restriction fragment length polymorph-
ism technique in molecular epidemiology [13].
Only a limited number of data are available about the
molecular epidemiological characteristics of MTBC in Italy
[6,7]. In the present study, we aimed to investigate the mo-
lecular epidemiological pattern of MTBC isolates in the
province of Palermo, Sicily, by characterizing a set of iso-
lates identified in the years 2004–2012 using spoligotyping
and the 24-loci MIRU-VNTR method. A comparison with
the findings obtained by restriction fragment length poly-
morphism (RFLP) typing of the IS6110 insertion sequence
and spoligotyping on a sample of 104 MTBC strains iden-
tified in the same geographic area in the years 1994–2000
[14,15] is also presented.
Methods
MTBC isolates
One hundred eighty-three MTBC isolates were analyzed
(Figure 1). In particular, 95 isolates were prospectively col-
lected during the year 2012 from patients admitted to the
three largest acute general hospitals in Palermo, Italy. More
specifically, the TB patients had been admitted to the
Infectious Disease Unit of the University teaching hospital
“Azienda Ospedaliero-Universitaria “Paolo Giaccone” and
to the Infectious Disease and Respiratory Disease Units of
the ARNAS Civico and Benfratelli hospital and Villa Sofia-
V. Cervello hospital. The isolates accounted for about 90%
of the isolates from laboratory-confirmed cases of TB
identified in 2012 in the province of Palermo. Eighty-eight
additional isolates were retrospectively recovered from a
collection of MTBC isolates identified from patients admit-
ted to Infectious Disease Unit of the University teaching
hospital in the years 2004–2011. They accounted for ap-
proximately 13% of the isolates from laboratory-confirmed
cases of TB in the province of Palermo in the same interval
of time. MTBC isolates were obtained from both pulmonary
(n = 168) and extra-pulmonary (n = 15) sites of infection.
Isolation had been carried out by routine methods on
mycobacterial growth indicator tubes (Bactec MGIT 960;
Becton Dickinson, Sparks, MD, US) and Lowenstein-Jensen
slants. identification of MTBC isolates to the species level
had been performed by a gene probe assay, according to
the manufacturer's protocol (GenoType MTBC; Hain Life-
science GmbH, Nehren, Germany). Shortly after identifica-
tion, the isolates had been stored at −70°C. For the study
purposes, MTBC isolates were newly inoculated in MGIT
and, subsequently, onto Lowenstein-Jensen slants and, after
about 4–6 weeks of incubation at 35°C, when an abundant
growth was apparent, all colonies were carefully suspended
into 500 μl of Tris-EDTA buffer, pH 8.0, and heated for
20 min at 80°C. Mycobacterial genomic DNA was extracted
by the QIAamp DNA Mini Kit (Qiagen, Germany). DNA
was quantitated and checked for purity by NanoDrop®
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ND-1000 spectrophotometer (ThermoScientific, Wilmington,
DE, US).
Susceptibility testing to streptomycin, isoniazid, rifam-
pin and ethambutol was carried out at the Department
of Sciences for Health Promotion and Mother-Child
Care “G. D’Alessandro”, University of Palermo, Italy,
using the mycobacterial growth indicator tube SIRE kit
(Becton Dickinson, Sparks, MD, US).
Informed consent was not required to patients because
the collection and typing of isolates followed their isola-
tion and identification as a part of the usual patient care
and no additional samples were necessary. All MTBC
isolates were anonymized before their handling for the
purposes of this study.
Molecular typing
Spoligotyping assays were performed as described previ-
ously using a microbead-based DNA array method at the
Institut de Génétique et Microbiologie UMR8621 CNRS-
University Paris-Sud [16]. The 24-loci MIRU-VNTR me-
thod was performed using an electrophoretic gel based
method in Palermo, Italy [17]. All results were transferred
into Excel spreadsheet files and imported into the Bionu-
merics v. 6.4 software (Applied Maths, St Martins Latem,
Belgium).
Genotypic lineage/sublineages were defined by entering
the genotyping results into the latest publicly available
SITVITWEB (http://www.pasteur-guadeloupe.fr:8081/
SITVIT_ONLINE/). Clusters were defined as groups of
patients infected with M. tuberculosis strains showing iden-
tical combined MIRU-VNTR and spoligotyping patterns.
Furthermore, the spoligotyping dataset obtained from
the MTBC isolates identified in the years 1994–2000 [15]
was reanalyzed in the light of the updated genetic diversity
database, by merging it into the SITVITWEB database.
The updated tags were used to newly label the previ-
ously characterized isolates. Minimum Spanning trees
(MSTs) using spoligotyping data were computed by the
Bionumerics software according with the manufacturer’s
instructions.
Statistical analysis
The statistical analysis was carried out using the EpiInfo
software (ver. 7.0.9.7), Centers for Disease Control and
Prevention, Atlanta, GA, US. Means and frequencies were
calculated and the significance of differences was assessed
by one-way ANOVA test or Kruskall-Wallis, when appro-
priate, or by the chi-square test or the Fisher’s exact test,
respectively. The associations between the variables under
examination were evaluated using contingency tables. All
reported P values were two-sided and P < 0.05 was consid-
ered significant.
Results
TB patients - years 2004–2011 and 2012
Among the 95 TB cases identified in the period 2004–
2011, 53 (55.8%) were Italian-born and 42 (44.2%) foreign-
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Figure 1 Flowchart of the study describing source of MTBC isolates and typing methods.
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women). The median age was 44.5 (interquartile range
[IQR] 32.0-62.0) years for Italian-born patients and 34.0
(IQR 25.5-46.0) years for immigrant patients, P = 0.002.
The proportion of foreign-born patients among the 88
culture-proven TB cases identified in 2012 was 42.1% (37
foreign-born vs. 51 Italian-born patients). The gender ratio
was 2.03 (59 men, 29 women). In this group of patients
the median age was significantly higher in the Italian-born
patients than in the foreign-born patients (Italian-born,
median 57.5, IQR 40.0-71.0, years vs. foreign-born, median
34.5, IQR 29.5-46.5, years, P < 0.001).
There was not any statistically significant difference
between the patients identified in 2004–2011 and 2012
with respect to their demographic characteristics, except
for the significantly older median age of the Italian pa-
tients of the year 2012 compared to those of the period
2004–2011 (P = 0.04).
The country of birth was known for 32 out of 38
foreign-born TB cases bacteriologically-confirmed in 2012,
but only in six out of 41 TB patients whose isolates had
been collected in the years 2004–2011. Of the 38 foreign-
born patients with known geographic origin, 17 were from
Africa, 10 from Asia, nine from East Europe and two from
Central America.
Molecular typing of MTBC isolates
One hundred seventy-seven out the 183 isolates were
completely characterized by spoligo- and 24-loci MIRU-
VNTR typing (Figure 1). Because the two TB patients
groups of 2004–2011 and 2012, respectively, had similar
distribution by country of birth (Italian-born vs. foreign-
born), the results of molecular typing of isolates were
pooled and referred to the entire period 2004–2012.
Table 1 and Figure 2B summarize the distribution of
MTBC isolates into spoligotyping defined genotypic line-
ages and families/subfamilies. Eleven different lineages were
identified with the most represented being the Haarlem
lineage with 47 (26.5%) isolates, the T super-family with 34
(19.2%) isolates, the Latin American-Mediterranean (LAM)
lineage with 24 (13.6%) isolates and the S lineage with 15
(8.5%) isolates. The distribution of isolates of the T and
LAM families roughly reflected the proportion of Italian-
born and immigrant patients (Italian-born, T lineage 70.6%
and LAM lineage 71.0%), whereas within the Haarlem
lineage isolates from immigrants were disproportionately
represented (55.3%). The S lineage isolates were exclusively
detected in Italian patients (Table 1 and Figure 2B). They
were more frequent in 2012 than in the period 2004–2011
(nine out of 87, 10.3% vs. six out of 90, 6.7%). The patients
from whom the S isolates had been identified were older,
but not significantly, than the Italian patients affected by
other than S MTBC isolates (median age 71, IQR 42–75,
years vs. 50.5, IQR 35–66, years, P = 0.25).
Table 1 Distribution of the Mycobacterium tuberculosis
complex isolates identified in Palermo, Italy, in the years






Haarlem 47 H3 15 13
H1 5 6
H 1 5
H3 variant - 2




T2 T3 1 -
T5 1 -
LAM 24 LAM 9 10 4
LAM 5 2 1
LAM 1 1 1
LAM variant 1 1
LAM 3 1 -
LAM 4 1 -
LAM 1 -
S 15 S 15 -
CAM 14 CAM 8 3
CAM variant - 3
U 13 U 10 3
EAI 10 EAI2 Manilla 3 -
EAI3 India 1 2
EAI6 BGD1 - 2
EAI1 SOM - 1
EAI5 - 1




Turkish 5 Turkish variant - 3
Turkish - 2
X 4 X1 1 1
X2 1 -
X3 1 -
Bovis 4 Bovis BCG 2 -
Bovis 1 -
Bovis 1 1 -
Ural 1 Ural 1 1 -
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Four isolates were classified as M. bovis, of which two
as M. bovis BCG (bacillus Calmette-Guérin) sub-family.
A total of 27 (15.2%) strains were grouped into 10 clus-
ters including two to six isolates. Two of them, including
isolates belonging to the T and S lineages, grouped only
Italian patients, whereas five clusters containing isolates of
T, CAM or Turkish lineage included only non Italian pa-
tients. The remaining three clusters, including isolates of
Haarlem and LAM lineages, contained each an equal pro-
portion of Italian and non Italian patients. Two clusters,
including CAM and Haarlem isolates, respectively, con-
tained only isolates identified in 2012. The median age of
clustered patients was lower compared to those unclus-
tered, but not significantly (clustered vs. unclustered pa-
tients, median age 36.5, IQR 27.0-53.0, years vs. 40.5, IQR
31.0-55.0, years, P = 0.67).
Comparison with the MTBC isolates 1994–2000
When spoligotyping data available from 100 out of 104
MTBC isolates identified in the years 1994–2000 were
reanalyzed by merging them into the SITVITWEB data-
base, they were attributed with seven previously de-
scribed spoligotype lineages. Lineages T (30.8%), LAM
(29.8%), Haarlem (16.3%) and S (13.5%) were predomin-
ant (Table 2). In addition, five strains could not be linked
to a previously described lineage and were classified as
“undefined”. No MTBC isolates belonging to CAM, U,
CAS, Turkish and Ural lineages were identified. Of inter-
est, only six isolates from foreign-born patients were
present in the 1994–2000 dataset (Table 2).
Figure 2 shows the population structure based upon
spoligotyping data of the MTBC isolates from 1994–2000
(Figure 2A) and 2004–2012 (Figure 2B) and allows for a
1994-2000  (n = 100) 2004-2012  (n = 183)
A A
B B
Figure 2 Minimum Spanning Trees obtained from the spoligotyping dataset including 100 MTBC isolates identified in the period
1999–2004 and 183 MTBC isolates identified in the period 2004–2012. A: by country of birth (Italian/non Italian). B: by main genotype
families, Arrows indicate the “S” family.
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comparison of the respective distribution by main geno-
type families and by the country of birth of patients. The
prevalence of the Euro-American phylogeographic lineage,
including the spoligotype families T, Haarlem, LAM, S
and X, was decreasing from 91.3% among the old isolates
to 70.1% among the most recent ones (P < 0.001). Yet, the
more recent set of isolates appeared to be characterized
not only by a significant reduction of the proportion of
strains belonging to the Euro-American lineage associated
with the emergence of new spoligotype families, but also
by a rearrangement of the spoligotype families into the
same lineage, with the Haarlem family becoming more
prevalent than T and LAM and the S family declining
from 13.5% to 8.5% (Table 2). Of interest, among the
2004–2012 MTBC isolates, the previously undetected
CAM, U, CAS, Turkish and Ural lineages accounted for
22.0% of isolates (Table 2).
Drug resistance of MTBC isolates
Approximately 25% of the 183 MTBC isolates under
study proved to be resistant to at least one antiTB drug
with a higher prevalence within the isolates belonging to
the U, S and T lineages (Table 3). The proportion of iso-
lates resistant to one or more drugs did not significantly
differ among foreign-born patients and Italian-born pa-
tients, respectively (21 out of 79 isolates, 26.6% vs. 24
out of 104 isolates, 23.1%, P = 0.58). The global preva-
lence of isoniazid resistance was 13.7%, with U and S
isolates showing higher figures (Table 3). The proportion
of isoniazid resistant isolates was significantly higher
among the isolates from Italian-born patients, with a
proportion more than twice as high as that from immi-
grant patients (19 out of 104 isolates, 18.3% vs. six out
of 79 isolates, 7.6%, P = 0.04).
Three MDR isolates were detected of which two belong-
ing to the U lineage and one to the LAM9 sub-family. The
first two isolates were from two elderly Italian patients,
Table 2 Distribution by lineage and geographic source of patients of the two sets of Mycobacterium tuberculosis
complex isolates under study
Years 1994 - 2000 Years 2004-2012
No. of isolates No. of isolates
Lineage Total No. of isolates (%) Italian-born Foreign-born Total No. of isolates (%) Italian-born Foreign-born
T 32 (30.8) 30 2 34 (19.2) 24 10
LAM 31 (29.8) 30 1 24 (13.6) 17 7
Haarlem 17 (16.3) 16 1 47 (26.5) 21 26
S 14 (13.5) 14 - 15 (8.5) 15 -
T4 1 (0.9) - - - - -
EAI 3 (2.9) 1 2 10 (5.6) 4 6
X 1 (0.9) 1 - 4 (2.3) 3 1
CAM - - - 14 (7.9) 8 6
U - - - 13 (7.3) 10 3
CAS - - - 6 (3.4) 1 5
Turkish - - - 5 (2.8) - 5
Bovis - - - 4 (2.3) 4 -
Ural - - - 1 (0.6) 1 -
Undefined 5 5 - - - -
Table 3 Antimicrobial drug resistance profiles of the
Mycobacterium tuberculosis complex isolates by lineage,







Lineage No. (%)* No. (%)* No.
U 5 (38.5) 4 (30.8) 2
S 5 (33.3) 3 (20.0) -
T 8 (23.5) 4 (11.8) -
Haarlem 9 (19.1) 3 (6.4) -
LAM 2 (8.3) 2 (8.3) 1
CAM 7 3 -
Turkish 3 2 -
EAI 2 1 -
Bovis 2 2 -
CAS 1 1 -
ND 1 - -
Total, No. 183 45 (24.6) 25 (13.7) 3 (1.6)
*percentage is showed only when the total number of isolates belonging to
the lineage is >10.
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whilst the LAM9 isolate was from a 26-year old Eritrean
patient.
Discussion
The significant changes in TB epidemiology occurring in
the last decades in low-incidence countries require to
adopt fine-tuned investigation tools and to update strat-
egies for TB control. In these settings, indeed, the ana-
lysis of transmission settings and dynamics is becoming
increasingly complex due to ongoing striking socio-
economic and demographic changes.
Sicily has a complex history of migration and cultural
exchanges due to its strategic position at a crossroad of
population movements involving Europe, North-Africa
and the Eastern Mediterranean [18]. However, in the last
two decades the migration events are dramatically chan-
ging both qualitatively and quantitatively, so putting to-
gether foreign-born long-term residents from traditional
immigration countries with recently arrived migrants
from an increasingly wide range of countries [10]. As a
consequence, TB epidemiology is becoming a complex
blend of reactivation in the older portion of the autoch-
thonous people and in some groups of foreign-born in-
dividuals and recent transmission in the younger and
more vulnerable population subgroups. Concentration of
TB cases in hard-to-reach marginalized communities is
a further issue of concern [1,3,8].
Our molecular epidemiology study highlights some in-
teresting epidemiological features of TB in Palermo and
its province. The first is the wide heterogeneity of the
MTBC strains detected in the years 2004–2012 with the
identification of 11 lineages and 35 families-subfamilies.
For comparison, in another region of Italy, Tuscany, 10
lineages were identified among 1080 MTBC isolates
identified in the years 2002–2005 [6]. This feature is
even more evident when comparing the more recent dis-
tribution with that of the years 1994–2000, when seven
lineages could be identified after reanalyzing the old spo-
ligotyping dataset. Not only was the recent number of
lineages higher, but the distribution of isolates was sig-
nificantly different between the two consecutive periods
mirroring the increasing contribution of isolates from
foreign-born TB patients. Some lineages, consequently,
such as CAM, CAS, Turkish and URAL were only de-
tected in the second set of isolates. Moreover, the recip-
rocal trend of the declining T and LAM lineages vs. the
increasing Haarlem lineages was likely attributable to
the impact of isolates from immigrant patients. Interest-
ingly, 10 isolates belonging to the EAI lineage were also
identified and four of them were from Italian-born pa-
tients. The total prevalence of this lineage as well as its
frequency among Italian patients were higher compared
to previous reports from other Italian regions [6,19].
The autochthonous S lineage was exclusively detected
among Italian-born patients, according with previous re-
ports [6,7,19].
It was an interesting finding the detection among the
MTBC isolates under study of four M. bovis isolates, of
which two M. bovis BCG, from Italian-born patients.
Many southern Italy regions, including Sicily, are not
still officially declared bovine tuberculosis free [19].
Consequently, possible acquisition of M. bovis through
raw milk and raw milk products or through direct con-
tact with infected animals cannot be ruled out. On the
other hand, the presence of M. bovis BCG infections in
Italians, which has been previously reported in other
Italian regions, could be tentatively traced to the BCG
treatment of bladder cancer patients [7]. However, no
epidemiological data were available to test these
hypotheses.
Our data also show some interesting epidemiological
features of the clustered isolates. Four clusters including
only non Italian TB patients were attributed with the
newly detected lineages CAM and Turkish, whereas the
more consolidated lineages Haarlem and LAM charac-
terized the three clusters including isolates from both
Italian and non Italian TB patients. The intrinsic limits
of our isolate collection does not allow for drawing
meaningful epidemiological inferences.
From the data in Table 2, it appears that 75.4% of the
183 MTBC isolates under study were susceptible to all
anti-TB drugs tested, a lower proportion compared to pre-
vious Italian reports [6,7]. The prevalence of isoniazid
resistance and multidrug resistance is, on the contrary,
similar to previously described figures in Italy and other
low-incidence European countries [3,6,7]. The prevalence
of resistance to at least one first line drug was similar
among isolates from Italian-born and foreign-born pa-
tients. This finding, which is inconsistent compared with
some previously reported observations about a higher
prevalence of resistance among isolates from non-Italian
patients in other Italian regions, could be related to the
different patterns of countries of immigration and distri-
bution of some MTBC lineages, such as the Beijing clade,
which is both prevalent in some areas and frequently asso-
ciated to antiTB drug resistance [6,7].
A number of limitations should be considered when
interpreting our results. The collection of MTBC isolates
was likely not representative of the confirmed TB cases
in the geographic area under investigation. In particular,
the MTBC isolates identified in the years preceding
2012 were greatly underrepresented. The case mix of pa-
tients of the two periods, 2004–2011 and 2012, respect-
ively, was likely different because of the different
hospital specialty wards contributing to the collection of
data and isolates. This probably skewed the age profile
of the 2012 patients towards an older age group, so po-
tentially influencing some features of the MTBC lineage
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distribution, such as the S lineage prevalence. Moreover,
information about country of origin of the patients whom
these isolates were recovered from was lacking, preventing
us from associating more accurately molecular markers
and geographic source. On the other hand, these limita-
tions should have expectedly led to underestimate the gen-
etic heterogeneity of the isolates under study which was
conversely higher than that reported in more consistent
MTBC collections of isolates [6,7]. When comparing the
lineage distribution between the two periods, 1994–2000
and 2004–2012, the results have to be interpreted cau-
tiously because of the largely different composition of the
two patients populations (6.0% vs. more than 40% MTBC
isolates from foreign-born individuals). This ultimately
skewed our comparison, though mirroring the impressive
impact on TB epidemiology of the recent immigrant
people influx in our geographic area. Clustering of isolates
was also analyzed only for the purpose of comparing the
two subsequent periods of study, but it could not
provide information about possible recent transmission
chains. Eventually, availability of conventional epidemio-
logical data was limited.
Conclusions
Molecular epidemiology of TB in Sicily is still embryonic.
However, our data, though neither representative nor ex-
haustive, provide a picture of the molecular epidemiology
of TB in Palermo, the largest province of Sicily, in the last
years. The comparison between the present distribution of
spoligotypes and that of about 10 years ago in the same
geographic area suggests also how quickly and deeply the
TB epidemiology has changed in a relatively short interval
of time. This highlights the need for implementing an uni-
versal and continued laboratory-based surveillance of TB
in Sicily with the aim to monitor indigenous transmission
and import from high incidence countries and contribute
to the assessment of prevention and control strategies.
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